Reckitt Benckiser Group (OTCMKTS:RBGLY) Stock Price Crosses Below 200-Day Moving Average of $15.03

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $15.03 and traded as low as $13.31. Reckitt Benckiser Group shares last traded at $13.35, with a volume of 2,702,454 shares traded.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Berenberg Bank cut Reckitt Benckiser Group from a “buy” rating to a “hold” rating in a report on Friday, October 27th. Barclays dropped their price objective on Reckitt Benckiser Group from GBX 7,700 ($93.70) to GBX 7,400 ($90.05) in a report on Monday, October 2nd. HSBC cut Reckitt Benckiser Group from a “buy” rating to a “hold” rating in a report on Thursday, October 26th. Finally, BNP Paribas cut Reckitt Benckiser Group from a “neutral” rating to an “underperform” rating in a report on Tuesday, September 12th. One research analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $7,065.00.

Reckitt Benckiser Group Price Performance

The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.36 and a current ratio of 0.54. The stock has a 50-day moving average of $14.15 and a two-hundred day moving average of $15.03.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.